Citations 90

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis

Annals of Neurology | January 2, 2018 | Volume: 83 | Issue: 1 | Pages: 166-177

10.1002/ana.25131 | PMID 29293273

Objective To evaluate the incidence and prevalence of autoimmune encephalitis and compare it to that of infectious encephalitis. Methods We performed a population‐based comparative study of the incidence and prevalence of autoimmune and infectious encephalitis in Olmsted County, Minnesota. Autoimmune encephalitis diagnosis and subgroups were defined by 2016 diagnostic criteria, and infectious encephalitis diagnosis required a confirmed infectious pathogen. Age‐ and sex‐adjusted prevalence and incidence rates were calculated. Patients with encephalitis of uncertain etiology were excluded. Results The prevalence of autoimmune encephalitis on January 1, 2014 of 13.7/100,000 was not significantly different from that of all infectious encephalitides (11.6/100,000; p = 0.63) or the viral subcategory (8.3/100,000; p = 0.17). The incidence rates (1995–2015) of autoimmune and infectious encephalitis were 0.8/100,000 and 1.0/100,000 person‐years, respectively ( p = 0.58). The number of relapses or recurrent hospitalizations was higher for autoimmune than infectious encephalitis ( p = 0.03). The incidence of autoimmune encephalitis increased over time from 0.4/100,000 person‐years (1995–2005) to 1.2/100,000 person‐years (2006–2015; p = 0.02), attributable to increased detection of autoantibody‐positive cases. The incidence (2.8 vs 0.7/100,000 person‐years, p = 0.01) and prevalence (38.3 vs 13.7/100,000, p = 0.04) of autoimmune encephalitis was higher among African Americans than Caucasians. The prevalence of specific neural autoantibodies was as follows: myelin oligodendrocyte glycoprotein, 1.9/100,000; glutamic acid decarboxylase 65, 1.9/100,000; unclassified neural autoantibody, 1.4/100,000; leucine‐rich glioma‐inactivated protein 1, 0.7/100,000; collapsin response‐mediator protein 5, 0.7/100,000; N‐methyl‐D‐aspartate receptor, 0.6/100,000; antineuronal nuclear antibody type 2, 0.6/100,000; and glial fibrillary acidic protein α, 0.6/100,000. Interpretation This study shows that the prevalence and incidence of autoimmune encephalitis are comparable to infectious encephalitis, and its detection is increasing over time. Ann Neurol 2018;83:166–177
Clinical Reasoning: A 46-year-old man with persistent hiccups, cognitive dysfunction, and imbalance

Neurology | October 16, 2017 | Volume: 89 | Issue: 16 | Pages: No page available

10.1212/wnl.0000000000004523 | PMID 29038139

Emerging Subspecialties in Neurology: Autoimmune neurology

Neurology | September 11, 2017 | Volume: 89 | Issue: 11 | Pages: No page available

10.1212/wnl.0000000000004356 | PMID 28894037

Teaching Neuro Images : Prominent spinal cord atrophy and white matter changes in adult polyglucosan body disease

Neurology | May 15, 2017 | Volume: 88 | Issue: 20 | Pages: No page available

10.1212/wnl.0000000000003945 | PMID 28507268

Antiepileptic drug therapy in patients with autoimmune epilepsy

Neurology Neuroimmunology & Neuroinflammation | May 11, 2017 | Volume: 4 | Issue: 4 | Pages: No page available

10.1212/nxi.0000000000000353 | PMID 28680914

Striking basal ganglia imaging abnormalities in LGI1 ab faciobrachial dystonic seizures

Neurology Neuroimmunology & Neuroinflammation | March 15, 2017 | Volume: 4 | Issue: 3 | Pages: No page available

10.1212/nxi.0000000000000336 | PMID 28331893

Personality Changes, Executive Dysfunction, and Motor and Memory Impairment

JAMA Neurology | December 20, 2016 | Volume: 74 | Issue: 2 | Pages: 245

10.1001/jamaneurol.2016.2782 | PMID 27992633

Paroxysmal sneezing in NMOSD: Further evidence of the localization of the human sneeze center

Neurology Neuroimmunology & Neuroinflammation | October 29, 2016 | Volume: 4 | Issue: 1 | Pages: No page available

10.1212/nxi.0000000000000303 | PMID 27844040

A 72-Year-Old End-Stage Liver Disease Patient With Lethargy

Infectious Diseases in Clinical Practice | June 26, 2016 | Volume: 24 | Issue: 4 | Pages: 241-242

10.1097/ipc.0000000000000405

Metabotropic glutamate receptor type 1 autoimmunity

Neurology | February 18, 2016 | Volume: 86 | Issue: 11 | Pages: 1009-1013

10.1212/wnl.0000000000002476 | PMID 26888994